Aurobindo Pharma declined 1.03% to Rs 1,641 after the company announced that the US Food and Drug Administration (USFDA) has closed its inspection of the Raleigh plant in North Carolina, USA.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.